Ultrasound Assessment of Atherosclerotic Plaque Burden and Cardiovascular Risk: A 10-Year Prospective Study
NCT ID: NCT06933745
Last Updated: 2025-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
21029 participants
OBSERVATIONAL
2022-04-01
2025-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Advanced Ultrasound Methods in the Assessment of Carotid Plaque Instability
NCT03672955
Screening for Atherotic Plaques by Ultrasound for Assessing Cardiovascular Risk
NCT03499496
18F-fluoride (18F-NaF) PET for Identifying Coronary Atherosclerotic Plaques
NCT02607748
ShOckwave ballooN or Atherectomy With Rotablation in Calcified Coronary Artery Lesions, the SONAR Trial
NCT05208749
Atherosclerosis-Progression in Coronary Arteries Compared to Periphery Vessels
NCT03164174
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Time schedule: Study inclusion and baseline examinations took place in the period April 2022- March 20025.
Current status: Ultrasound follow-up examinations take place from January 2025 - December 2029.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants undergoing ultrasound and screening for conventional CV risk factors.
A sub-cohort consists of 5 500 participants who undergo both carotid and femoral ultrasound and fatty liver status assessment by ultrasound, in addition to assessement of traditional CV risk factors including history of smoking, total-cholesterol, LDL-cholesterol, HDL-cholesterol, Lp(a), blood glucose, systolic and diastolic blood pressure and waist circumference measurements.
No interventions assigned to this group
Participants undergoing ultrasound examination
Total cohort consists of 22 000 participants who undergo both carotid and femoral ultrasound and fatty liver status assessment by ultrasound
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
45 Years
74 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oslo
OTHER
University Hospital, Akershus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jonn Terje Geitung
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonn-Terje Geitung, MD, PhD, MHA
Role: PRINCIPAL_INVESTIGATOR
University of Oslo
Serena N.H. Tonstad, MD, PhD
Role: STUDY_DIRECTOR
Oslo University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Austad Diagnostikk
Oslo, East, Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ahus, BDA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.